Search
for
Sort by
Research 511–540 of 1000+
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- Treatment of alopecia areata with JAK inhibitors
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- JAK inhibitors for the treatment of alopecia areata
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis